NY State Senate Bill 2025-S3891

Senate Bill S3891

2025-2026 Legislative Session

Authorizes and directs the department of health to conduct a study on drugs prescribed for school age children with ADD and ADHD

download bill text pdf

Current Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 30, 2025	referred to health

2025-S3891 (ACTIVE) - Details

Current Committee:: Senate Health
Law Section:: Health, Commissioner of
Versions Introduced in Other Legislative Sessions:: 2009-2010: S8202
2011-2012: S1172
2013-2014: S3100
2015-2016: S2761
2017-2018: S2193
2019-2020: S2599
2021-2022: S3167
2023-2024: S4677

2025-S3891 (ACTIVE) - Summary

Authorizes and directs the department of health to conduct a study on drugs prescribed for school-age children with ADD and ADHD.

2025-S3891 (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S3891

SPONSOR: PARKER
 
TITLE OF BILL:

An act authorizing and directing the department of health to do research
and study as to the effects of psychostimulants, selective seratonin
reuptake inhibitors, antidepressants and other drugs which are
prescribed for attention deficit disorders, ADD and ADHD, for school age
children

 
PURPOSE OR GENERAL IDEA OF THE BILL:

To conduct a study on drugs prescribed for school-age children with ADD
and ADHD, making recommendations thereafter.

 
SUMMARY OF SPECIFIC PROVISIONS:

Authorizes the commissioner of health, in conjunction with the commis-
sioner of mental health, the commissioner of Developmental Disabilities
and the commissioner of education to conduct a study and do research as
to the effect of psycho stimulants, selective serotonin reuptake inhibi-

tors, antidepressants and other drugs prescribed for ADD and ADHD, In
school age children. The commissioner shall report his or her findings
to the governor, the speaker of the assembly and the temporary president
of the senate within two years that this act shall take effect.

 
JUSTIFICATION:

Currently 5 million school kids in America are on psychotropic drugs.
The Centers for Disease Control and Prevention (CDC) looked at drug
overdose deaths among children ages 15 to 19 over a 16-year period, from
1999 to 2015, and showed that from 1999 to the mid-2000s drug overdose
deaths in this age group more than doubled from 1.6 deaths per 100,000
in 1999 to 4.2 deaths per 100,000 in 2007).

Kids are routinely being misdiagnosed and forced to take drugs for
behavior problems, often containing violent side effects. This problem
is becoming an epidemic with no end in sight. It is imperative that the
commissioner DOH performs a study on the effects of medicating our
school children, and making recommendations thereafter.

 
PRIOR LEGISLATIVE HISTORY:

2023-24: S4677-Referred to Health

2021-22: S3167- Referred to Health

2019-20: S2599- Referred to Health

2017-18: S2193 - Referred to Health

2015-16: S.2761 - Referred to Health

2013-14: S.3100 - Referred to Health

2011-12: S.1172 - Referred to Health

2009-10: S.8202/A.5602 - Passed Both Houses, Vetoed Memo 6752
2008-09: A.5388 - Passed Assembly 2007-08: A.5388 - Passed Assembly

2006-07: A.5885A - Passed Assembly 2005-06: A.5885 - Health

 
EFFECTIVE DATE:
This act shall take effect immediately

2025-S3891 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   3891
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                             January 30, 2025
                                ___________
 
 Introduced  by  Sen.  PARKER -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT authorizing and directing the department of health to do research
   and study as to the effects of psychostimulants,  selective  seratonin
   reuptake   inhibitors,  antidepressants  and  other  drugs  which  are
   prescribed for attention deficit disorders, ADD and ADHD,  for  school
   age children
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. 1.  The commissioner of health,  in  conjunction  with  the
 commissioner  of  mental health, the commissioner of developmental disa-
 bilities, and the commissioner of education is authorized  and  directed
 to conduct a study and do research as to the effect of psychostimulants,
 selective serotonin reuptake inhibitors, antidepressants and other drugs
 prescribed for attention deficit disorder, attention deficit hyperactiv-
 ity  disorder, and the increasing rate of diagnosis of these conditions,
 in school age children.
   2. The study shall be conducted in accordance with rules,  regulations
 and  standards  determined  by the commissioner of health, and the study
 shall concentrate on harmful side effects of such drugs,  the  appropri-
 ateness  and effectiveness of tools and methods used to assess and diag-
 nose the condition, the appropriateness of  different  medications,  and
 any demographic disparities in diagnosis.
   3.  The  commissioner of health shall report the findings of the study
 to the governor, the speaker of the assembly and the temporary president
 of the senate on or before two years from the date this act  shall  take
 effect.
   § 2. This act shall take effect immediately.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD06855-01-5

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.